4D Pharma PLC (DDDD:LSE) Investor Relations Material

Overview

4D Pharma PLC is a top company in the development of Live Biotherapeutics, a new class of drugs that includes live organisms to prevent, treat, or cure diseases. The company boasts a state-of-the-art discovery platform, MicroRx, that precisely identifies bacterial drug candidates based on a thorough understanding of function and mechanism. These Live Biotherapeutic products consist of singular strains of bacteria that naturally occurs in the human gut and are administered orally. 4D Pharma PLC is at the forefront of developing novel ways of treating diseases and is revolutionizing the healthcare industry.

Frequently Asked Questions

What is 4D Pharma PLC's ticker?

4D Pharma PLC's ticker is DDDD

What exchange is 4D Pharma PLC traded on?

The company's shares trade on the LSE stock exchange

Where are 4D Pharma PLC's headquarters?

They are based in Leeds, England

How many employees does 4D Pharma PLC have?

There are 51-200 employees working at 4D Pharma PLC

What is 4D Pharma PLC's website?

It is https://www.4dpharmaplc.com/

What type of sector is 4D Pharma PLC?

4D Pharma PLC is in the Healthcare sector

What type of industry is 4D Pharma PLC?

4D Pharma PLC is in the Biotechnology industry

Who are 4D Pharma PLC's peers and competitors?

The following five companies are 4D Pharma PLC's industry peers:

- Cortexyme, Inc.

- Tiziana Life Sciences plc

- Alkermes

- Cabaletta Bio, Inc.

- Inovio Pharmaceuticals